Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Home
Stem Cell Veto Could Hurt U.S. Competitiveness, Says William Caldwell, CEO of Advanced Cell Technology
Caldwell's company is working on stem-cell-based therapies for macular degeneration. Bloomberg TV interviewed him this week for his views. Watch
here.
pharmamanufacturing
June 22, 2007
Add Us On Google
Caldwell's company is working on stem-cell-based therapies for macular degeneration. Bloomberg TV interviewed him this week for his views. Watch
here.
About the Author
pharmamanufacturing
pharmamanufacturing
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Halo Pharma targets sterile injectable manufacturing at Whippany, NJ site
Bristol Myers Squibb to build $2.3B manufacturing campus in Houston
Biologics, GLP-1s driving evolution of fill-finish manufacturing
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content